Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
350,912
Value
$88.3M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026350,912$88.3M0.5%−161,033−31.5%ReducedHolders
Q1 2026511,945$111.3M0.8%+32,393+6.8%AddedHolders
Q4 2025479,552$109.6M0.8%+15,898+3.4%AddedHolders
Q3 2025463,654$107.4M0.9%+12,379+2.7%AddedHolders
Q2 2025451,275$83.8M0.7%+107,804+31.4%AddedHolders
Q1 2025343,471$72.0M0.7%+4,597+1.4%AddedHolders
Q4 2024338,874$60.2M0.5%−631−0.2%ReducedHolders
Q3 2024339,505$67.0M0.6%+6,919+2.1%AddedHolders
Q2 2024332,586$57.0M0.6%−86,817−20.7%ReducedHolders
Q1 2024419,403$76.4M0.8%+6,803+1.6%AddedHolders
Q4 2023412,600$63.9M0.8%+7,001+1.7%AddedHolders
Q3 2023405,599$60.5M0.8%+3,109+0.8%AddedHolders
Q2 2023402,490$54.2M0.7%+4,966+1.2%AddedHolders
Q1 2023397,524$63.4M0.9%+8,004+2.1%AddedHolders
Q4 2022389,520$63.0M1.0%+34,407+9.7%AddedHolders
Q3 2022355,113$47.7M0.9%+25,491+7.7%AddedHolders
Q2 2022329,622$50.5M1.0%−8,602−2.5%ReducedHolders
Q1 2022338,224$54.8M0.9%+28,895+9.3%AddedHolders
Q4 2021309,329$41.9M0.7%+24,162+8.5%AddedHolders
Q3 2021285,167$30.8M0.6%−50,291−15.0%ReducedHolders
Q2 2021335,458$37.8M0.7%+10,375+3.2%AddedHolders
Q1 2021325,083$35.2M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.